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Abstract 
Background: To study anti inflammatory effect of 
Dexamethasone versus Diclofenac Sodium after 
phacoemulsification with posterior chamber 
intraocular lens implantation 
Method:  The study included 232 cases selected at 
random from the in patient department. They were 
divided into two groups, 116 in each group. Patients 
ranged in age from 4th to 7th decade.Group A 
received non steroidal anti inflammatory drug, 
diclofenac sodium and group B received steroid, 
dexamethasone as postoperative anti inflammatory 
drug. Data related to cells and flare was collected 
using Haag-Streit slit lamp biomicroscope with 3mm 
x 1mm oblique slit at high intensity of light and 
magnification x16 in a dark room. Patients were then 
asked to follow the specified regimen of 1 drop of 
drug every 6 hours in operated eye. Patients were  
followed on day 3, 7 and then after 2 weeks and 4 
weeks.  
Results: The cells on first post operative day ranged 
mainly from +1 to +4 grades of cells.On subsequent 
follow up visits the anterior chamber activity 
recorded separately for each group decreased to zero 
till the fourth week.The flare on first post operative 
day ranged mainly from +1 to +3 in severity. On 
subsequent follow up visits the flare decreased to 
zero till the fourth week in both groups. 
Conclusion:Anti inflammatory effect of diclofenac 
sodium is comparable to a potent steroid 
dexamethasone. 
 
Introduction 
     Improvement in surgical technique and intraocular 
lens design has contributed to excellent clinical results 
after cataract surgery.1 However an acute 
postoperative inflammation occurs during the early 
post operative days with an incidence of 8.4%.2 Early 
onset postoperative inflammation occurs due to 
surgical trauma leading to disruption of blood 
aqueous barrier and leakage of protein and cells into 
anterior chamber which causes a trigger of the 
inflammatory cascade. That in turn generates 
prostaglandins by activation of cyclooxygenases and 
lipooxygenases.1,2  Anti-inflammatory therapy to 
hasten the resolution and avoid complications of 
prolonged inflammation, like pain, photophobia, 
foreign body sensation, reduced visual acuity, 
posterior synechiae, raised intra ocular pressure and 
cystoid macular edema.3, 4 
     Topical steroids are known to be effective in 
suppressing postoperative inflammation. However, 
they have side effects such as elevation of intraocular 
pressure, delayed wound healing, increased tendency 
of infections and epithelial toxicity.5 Studies have 
shown some of the NSAIDs are as effective as steroids 
in reduction of pain, discomfort and controlling 
postoperative inflammation with less adverse effects.2,6 
NSAIDs decrease inflammation by inhibiting 
cyclooxygenases 1 and 2, and reducing synthesis of 
prostaglandins that mediate inflammation. They are 
comparable to steroids in reducing inflammation.2 In 
reference to different studies steroids show 90% 
efficacy and NSAIDs show 76.3% efficacy at mild level 
of inflammation postoperatively. 3,6 
 
Patients  and Methods 
     This randomized control study was conducted in 
Department of Ophthalmology, Holy Family Hospital, 
Rawalpindi, from 5th October 2011 to 4th April 2012.  
Patients were allocated to group A or group B 
randomly by lottery method. Dexamethasone and 
diclofenac sodium eye drops were  instilled in 
operated eye to patients of group A and B 
respectively. Data related to cells and flare was 
collected using Haag-Streit slit lamp biomicroscope 
with 3mm x 1mm oblique slit at high intensity of light 
and magnification x16 in a dark room. Patients were 
then be asked to follow the specified regimen of 1 drop 
of drug every 6 hours in operated eye. Patients were 
asked to return for follow up on day 3, 7 and then after 
2 weeks and 4 weeks.  
Results 
     Mean age of the patients was 59.98 ± 9.11 years with 
age range of 40 – 75 years. On first post operative day 
majority of the patients (45.3%) had +III cell 
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involvement (Table 1).On final follow up, there were 
99.14% and 97.41% patients who had no cell while in 
group A and group B there were 0.86% and 2.59% had 
II (+2) cells respectively. At Final follow up the grade 
of cells were same in both study groups, i.e. p-value = 
0.313(Table 2). At first follow up,14.7% and 7.8% 
patients had I(+1) flare in group A and B respectively. 
Grade II (+2) flare was seen in 32.8% and 30.2% of the 
patients in group A and group B. There were 52.6% 
patients in group A and 62.1% of the patients in group 
B who had grade III (+3) flare. Statistically the grade of 
flare was same in both study groups, i.e. p-value 
0.174(Table 3).  
   At final follow up, 2 patients in each group had III 
(+3) flare while 98.27% patients in each group had no 
flare. The grade of flare was same in both study 
groups (Table 3).At final follow up the mean grade of 
cells were 3.08 ± 0.88 in group A and 3.22±0.72 in 
group B. The mean grade of flare in group A and B 
were 2.38 ± 0.73 and 2.54 ± 0.64 respectively. The 
average visual acuity at final follow up was 6/ 
(6.9±0.14) in group A and 6 / (6.8 ± 0.13) in group 
B(Table 5).In group A and group B the treatment was 
effective in 99.1% and 97.4%, respectively.According 
to chi-square, both the treatments were equally 
effective in this study, p-value = 0.313 (Table 6).   
Table 1:Comparison of Cells inflammation in both 
study  groups (First Post-Operative) 
 Study Groups Total A B 
Cells 
I(+1) 8 (6.9%) 2 (1.7%) 10 (4.3%) 
II(+2) 17 (14.7%) 14 (12.1%) 31 (13.4%) 
III(+3) 49 (42.2%) 56 (48.3%) 105(45.3%) 
IV(+4) 42 (36.2%) 44 (37.9%) 86 (37.1%) 
Total 116 (100%) 116(100%) 232 (100%) 
p-value = 0.221 (in-significant) 
Table  2:Comparison of Cells inflammation in both 
study  groups (Final Follow up) 
 Study Groups Total 
A B 
Cells 
0 115 (99.14) 113 (97.41%) 228 (98.27) 
I(+1) 0 (0%) 0 (0%) 0 (0%) 
II(+2) 1 (0.86%) 3 (2.59%) 4 (1.73) 
Total 116 (100%) 116 (100%) 232 (100%) 
p-value = 0.313 (in-significant) 
 
Discussion 
     Previously there was greater need for anti-
inflammatory treatment after cataract surgery due to 
greater surgical trauma in extra capsular cataract 
extraction. With the advent of phacoemulsification and 
foldable intraocular lens implantation the surgical 
trauma has greatly reduced and also the need for very  
Table  3:Comparison of flare inflammation in both 
study  groups (First Post Operative) 
 
Study Groups 
Total A B 
Flare  
I(+1) 17 (14.7%) 9 (7.8%) 26 (11.2%) 
II(+2) 38 (32.8%) 35 (30.2%) 73 (31.5%) 
 III(+3) 61 (52.6%) 72 (62.1%) 133 (57.3%) 
Total 116 (100%) 116 (100%) 232 (100%) 
P-value = 0.174 (in-significant) 
 
Table  4:Comparison of Flare inflammation in both  
study groups(Final Follow up) 
 
Study Groups 
Total 
A B 
No. of 
Flare 
0 114 (98.27%) 114 (98.27%) 228 (98.27%) 
I(+1) 0 (0%) 0 (0%) 0 (0%) 
II(+2) 0 (0%) 0 (0%) 0 (0%) 
III(+3) 2 (1.72%) 2 (1.72%) 4 (1.72%) 
Total 116 (100%) 116 (100%) 232 (100%) 
P-value = 1 
Table  5:Descriptive Statistics of grade of Cells, Flare 
and Visual  Acuity (Final) in both study groups 
 Study groups  
A B 
Cells Mean ± S.D 3.08 ± 0.88 3.22 ± 0.72 
Flare Mean ± S.D 2.38 ± 0.73 2.54 ± 0.64 
Visual 
Acuity  
(Final )  
Mean ± S.D 6/ (6.9 ± 
0.14) 
6 / (6.8 ± 
0.13) 
 
Table 6: Comparison of efficacy of interventions in 
both the groups 
Treatment 
Efficacy 
Effective 
No(%) 
Not Effective 
No(%) 
Group A 115(99.1) 1(0.9) 
Group B 113(97.4) 3(2.6) 
 
potent anti inflammatory medication.7 
    The inflammation after phacoemulsification settles 
after the BAB recovery but can have certain side effects 
such as posterior synechiae, elevated intraocular 
pressure, delayed recovery of visual acuity and 
cystoid macular edema.8 
     It is a routine practice to use steroids after cataract 
surgery. Steroids interfere with the inflammatory 
response in a variety of ways, one of which is the 
inhibition of arachidonic acid synthesis .But the steroid 
treatment can have many side effects such as increased 
IOP, delayed wound healing and increased chance of 
post operative ocular infection. 9 
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     Diclofenac indirectly modulates also the 
lipoxygenase pathway in the arachidonic acid cascade. 
This dual mechanism of action of diclofenac may make 
it comparable in anti-inflammatory activity to the 
corticosteroids as mentioned by Laurell.10 The 
potential advantages of using NSAIDs after cataract 
surgery are the lack of IOP rise and decreased 
impairment of wound healing. Thus NSAIDs can be 
used after cataract surgery to control inflammation as 
shown in study.11 
     One of the study reported by Roberts even showed 
NSAIDs to be superior to steroids in recovery of 
BAB.12 Our results show that NSAID diclofenac 
sodium is an effective anti-inflammatory agent for the 
control of postoperative inflammation after cataract 
surgery while all the patients in our study were 
otherwise free of any inflammatory disease and the 
surgery was uncomplicated in all the patients with 
only a mild amount of postoperative inflammation.  
    Anterior chamber inflammation is measured in 
terms of cells and flare. We used the non invasive 
subjective technique of counting cell and flare in the 
anterior chamber, i.e., slit lamp. Studies have been 
done by using slit lamp assessment of cell and flare 
alone, and also in conjunction with the very recent 
sophisticated computerized technique that is laser cell 
and flare meter which measures the cell and flare 
objectively in a very short period of time. 
 There are studies in which the postoperative 
inflammation was evaluated subjectively by slit lamp 
assessment of cell and flare and objectively by 
measurement of cells and flare with a laser cell and 
flare meter. The results were comparable.The study 
reported by Hirneiss used slit lamp for assessment of 
cell and flare13.  
Conclusion 
1. The anti inflammatory effect of diclofenac 
sodium is comparable to a potent steroid 
dexamethasone. 
2. No side effect of either drug was observed in 
30 days of follow up period. 
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